↓ Skip to main content

Cochrane Database of Systematic Reviews

Statins for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis

Overview of attention for article published in Cochrane database of systematic reviews, December 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
5 X users

Citations

dimensions_citation
140 Dimensions

Readers on

mendeley
212 Mendeley
citeulike
1 CiteULike
Title
Statins for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis
Published in
Cochrane database of systematic reviews, December 2013
DOI 10.1002/14651858.cd008623.pub2
Pubmed ID
Authors

Layli Eslami, Shahin Merat, Reza Malekzadeh, Siavosh Nasseri‐Moghaddam, Hermineh Aramin

Abstract

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are common causes of elevated liver enzymes in the general population. NASH and to some extent NAFLD have been associated with increased liver-related and all-cause mortality. No effective treatment is yet available. Recent reports have shown that the use of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) in patients with elevated plasma aminotransferases may result in normalisation of these liver enzymes. Whether this is a consistent effect or whether it can lead to improved clinical outcomes beyond normalisation of abnormal liver enzymes is not clear.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 212 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Ireland 1 <1%
Australia 1 <1%
South Africa 1 <1%
United Kingdom 1 <1%
Mexico 1 <1%
Spain 1 <1%
Unknown 205 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 28 13%
Researcher 25 12%
Student > Bachelor 23 11%
Student > Ph. D. Student 20 9%
Other 18 8%
Other 31 15%
Unknown 67 32%
Readers by discipline Count As %
Medicine and Dentistry 83 39%
Nursing and Health Professions 15 7%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Biochemistry, Genetics and Molecular Biology 7 3%
Agricultural and Biological Sciences 3 1%
Other 14 7%
Unknown 82 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2022.
All research outputs
#2,387,435
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#4,829
of 11,499 outputs
Outputs of similar age
#26,512
of 320,506 outputs
Outputs of similar age from Cochrane database of systematic reviews
#106
of 219 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,506 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 219 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.